Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-03-15 @ 9:01 AM
Study NCT ID:
NCT03976518
Status:
COMPLETED
Last Update Posted:
2024-03-01
First Post:
2019-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial)
Sponsor:
Gruppo Oncologico Italiano di Ricerca Clinica
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GOIRC-02-2018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None